Obesity Market to Observe Impressive Growth by 2034, Assesses DelveInsight | Key Companies – Novo Nordisk A/S, Pfizer, Boehringer Ingelheim, Eli Lilly and Company, Rhythm Pharmaceuticals, Harmony Biosciences

The obesity market size is projected to witness growth from 2024 to 2034 due to the rising prevalence of obesity. This expansion is expected to be further influenced by the extensive pipeline of emerging drugs, characterized by lower safety risks and improved profiles, throughout the…